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Abstract: Magnesium gluconate is a classical pharmaceutical/nutraceutical compound used as a magnesium ion source for 
the prevention and treatment of hypomagnesemia. The present study was aimed to investigate the effect of The Trivedi Effect
® 
- Energy of Consciousness Healing Treatment (Biofield Energy Healing Treatment) on magnesium gluconate for the change in 
the structural properties and isotopic abundance ratio (PM+1/PM and PM+2/PM) using LC-MS and NMR spectroscopy. 
Magnesium gluconate was divided into two parts – one part was control, and another part was treated with The Trivedi Effect
® 
- Biofield Energy Healing Treatment remotely by twenty renowned Biofield Energy Healers and defined as The Trivedi 
Effect
® 
Treated sample. The LC-MS analysis of both the control and treated samples indicated the presence of mass of the 
protonated magnesium gluconate at m/z 415 at the retention time of 1.52 min and fragmentation pattern of the both sample 
were almost similar. The relative peak intensities of the fragment ions were significantly changed in the treated sample 
compared with the control sample. The proton and carbon signals for CH, CH2 and CO groups in the proton and carbon NMR 
spectra were observed almost similar for the control and the treated samples. The percentage change in the isotopic abundance 
ratio of PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) was significantly decreased in the treated sample by 17.51% 
compared with the control sample. Consequently, the isotopic abundance ratio of PM+2/PM (
18
O/
16
O or 
26
Mg/
24
Mg) in the treated 
sample was significantly increased by 79.44% compared to the control sample. Briefly, 
13
C, 
2
H, 
17
O, and 
25
Mg contributions 
from (C12H23MgO14)
+
 to m/z 416; 
18
O and 
26
Mg contributions from (C12H23MgO14)
+
 to m/z 417 in treated sample were 
significantly altered compared with the control sample. Thus, The Trivedi Effect
®
 Treated magnesium gluconate might be 
supportive to design the novel potent enzyme inhibitors using its kinetic isotope effects. Consequently, The Trivedi Effect
®
 
Treated magnesium gluconate would be valuable for designing better pharmaceutical and/or nutraceutical formulations through 
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its changed physicochemical and thermal properties, which might be providing better therapeutic response against various 
diseases such as diabetes mellitus, allergy, aging, inflammatory diseases, immunological disorders, and other chronic 
infections. 
Keywords: Magnesium Gluconate, Biofield Energy Healing Treatment, Consciousness Energy Healing Treatment,  
Biofield Energy Healers, The Trivedi Effect
®
, LC-MS, NMR, Isotopic Abundance Ratio, Isotope Effect 
 
1. Introduction 
Magnesium gluconate is a classical pharmaceutical/ 
nutraceutical compound used for the source of magnesium 
ion, a major and essential mineral in the human body [1]. 
Magnesium is a vital element for more than 300 enzymes, 
DNA and RNA synthesis, reproduction and protein synthesis 
as well as a vital coherent controller of glycolysis and the 
Krebs cycle [2, 3]. Hypomagnesemia may cause several 
diseases and disorders [4-7]. Magnesium gluconate is found 
to be the most physiologically acceptable antioxidant and 
showed the highest level of bioavailability of magnesium 
among the commercially available magnesium salts such as 
chloride, sulfate, citrate, lactate, aspartate, etc. [8-10]. Thus, 
magnesium gluconate has the important application for the 
prevention and treatment of diabetes mellitus, allergies, 
cardiovascular diseases, septic shock, inflammatory diseases, 
immunological disorders, arrhythmias, acute myocardial 
infarction, gestational hypertension, preeclampsia, eclampsia, 
Alzheimer's disease, cancer, and oxidative stress induced 
ischemia/reperfusion injury [4-7, 9-11]. It can be used as 
neuroprotective [12], an oral tocolytic agent [13], and also in 
a skin-tightening cosmetic composition [14]. Subsequently, 
magnesium gluconate was considered as one of the 
components in a novel proprietary herbomineral formulation, 
which is designed as nutraceutical for the source of 
magnesium ion. 
Since ancient times, many different cultures, religions and 
systems of belief have recognized a living force that preserves 
and inhabits every living organism. This force is the source of 
‘life’ and has been called various names, such as prana by the 
Hindus, qi or chi by the Chinese, and ki by the Japanese. This 
is believed to co-relate with the soul, spirit and mind. This 
hypothetical vital force has been scientifically evaluated and is 
now considered the Bioenergetics Field. The Biofield Energy 
is a dynamic electromagnetic field surrounding the human 
body, resulting from the continuous emission of low-level 
light, heat, and acoustical energy from the body. Biofield 
Energy is infinite, para-dimensional and can freely flow 
between the human and environment [15]. F. Sances et al. 
reported that Biofield Energy can be transmitted into any 
living organism (s) or nonliving object (s) around the globe 
with scientifically measurable effect through the intentional 
mental energies by specific energy healers [16]. The object or 
recipient always receives the energy from the ionosphere of the 
earth, the “universal energy field” and responds in a useful 
way. This process is known as The Trivedi Effect
®
 - Biofield 
Energy Healing Treatment [17, 18]. Biofield (Putative Energy 
Field) based Energy Therapies are used worldwide to promote 
health and healing. The National Center of Complementary 
and Integrative Health (NCCIH) has recognized and accepted 
Biofield Energy Healing as a Complementary and Alternative 
Medicine (CAM) health care approach in addition to other 
therapies, medicines and practices such as natural products, 
deep breathing, yoga, Tai Chi, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, massage, 
special diets, homeopathy, progressive relaxation, guided 
imagery, acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, cranial sacral 
therapy and applied prayer (as is common in all religions, like 
Christianity, Hinduism, Buddhism and Judaism) [19]. Biofield 
Energy Treatment (The Trivedi Effect
®
) has been drawn 
attention more in the recent times for its scientifically 
measurable capability to transform the characteristic properties 
of a wide varieties living and non-living substances such as 
microbes [20, 21], cancer cells [22], plants [23, 24], animals 
[25], medium [26, 27], materials [28, 29], pharmaceuticals [30, 
31], nutraceuticals [32, 33], organic compounds [34, 35]. The 
scientific study indicated that Biofield Energy Healing 
Treatment (The Trivedi Effect
®
) might be an alternate method 
for increasing or decreasing the natural isotopic abundance 
ratio of the substances [36-39]. The stable isotope ratio 
analysis has the broad application in several scientific fields 
for understanding the isotope effects resulting from the 
difference of the isotopic composition of the molecule [40, 41]. 
Conventional mass spectrometry (MS) techniques such as 
liquid chromatography-mass spectrometry (LC-MS), gas 
chromatography-mass spectrometry (GC-MS) are extensively 
used for isotope ratio analysis with sufficient precision [42]. 
Hence, LC-MS and NMR (Nuclear Magnetic Resonance) 
methods were applied in this research work to depict the 
structural properties of the Biofield Energy Treated and 
untreated magnesium gluconate. Consequently, the authors 
sought to explore the impact of The Trivedi Effect
®
 
(Consciousness Energy Healing Treatment) on the isotopic 
abundance ratios of PM+1/PM and PM+2/PM in magnesium 
gluconate using LC-MS based isotopic abundance ratio 
analysis in both the Biofield Energy Treated and untreated 
samples. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Magnesium gluconate hydrate was purchased from Tokyo 
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Chemical Industry Co., Ltd. (TCI), Japan. All other 
chemicals used in the experiment were of analytical grade 
available in India. 
2.2. Energy of Consciousness Healing Treatment Strategies 
Magnesium gluconate was one of the components of the 
new proprietary herbomineral formulation, which was 
developed by our research team and was used per se as the 
test compound for the current study. The test compound was 
divided into two parts, one part of the test compound did not 
receive any sort of treatment and was defined as the untreated 
or control magnesium gluconate sample. The second part of 
the test compound was subjected to The Trivedi Effect
®
 - 
Energy of Consciousness Healing Treatment (Biofield 
Energy Healing Treatment) by a group of twenty renowned 
Biofield Energy Healers remotely and was denoted as The 
Trivedi Effect
®
 - Biofield Energy treated sample. Thirteen 
Biofield Energy Healers were remotely located in the U. S. 
A., five were located in Canada, and two were located in 
Australia, while the test compound was located in the 
research laboratory of GVK Biosciences Pvt. Ltd., 
Hyderabad, India. The Trivedi Effect
®
 - Energy of 
Consciousness Healing Treatment (Biofield Energy Healing 
Treatment) was provided for 5 minutes through the Healer’s 
Unique Energy Transmission process remotely to the test 
compound, which was kept under laboratory conditions. 
None of the Biofield Energy Healers in this study visited the 
laboratory in person, nor had any contact with the 
compounds. Similarly, the control compound was subjected 
to “sham” healer for 5 minutes, under the same laboratory 
conditions. The sham healer did not have any knowledge 
about the Biofield Energy Treatment. After that, The Trivedi 
Effect
® 
treated and untreated samples were kept in similar 
sealed conditions and characterized thoroughly by LC-MS 
and NMR spectroscopy. 
2.3. Liquid Chromatography Mass Spectrometry (LC-MS) 
Analysis 
Liquid chromatography was performed using The Waters
®
 
ACQUITY UPLC, Milford, MA, USA equipped with a 
binary pump (The Waters
®
 BSM HPLC pump), autosampler, 
column heater and a photo-diode array (PDA) detector. The 
column used for the study was a reversed phase Acquity 
BEH shield RP C18 (150 X 3.0 mm, 2.5 µm). The column 
temperature was kept constant at 40°C. The mobile phase 
was 2mM ammonium acetate in water as mobile phase A and 
acetonitrile as mobile phase B. Chromatographic separation 
was achieved with following gradient program: 0 min – 
5%B; 1 min – 5%B; 15 min - 97%B; 20 min – 97%B; 21 min 
– 5%B; 25 min – 5%B. The flow rate was at a constant flow 
rate of 0.4 mL/min. The control and treated samples were 
dissolved in a mixture of water and methanol (60:40 v/v) to 
prepare a 1 mg/mL stock solution. An aliquot of 2 µL of the 
stock solution was used for analysis by LC-ESI-MS and the 
total run time was 25 min. Mass spectrometric analysis was 
accompanied on a Triple Quad (Waters Quattro Premier XE, 
USA) mass spectrometer equipped with an electrospray 
ionization (ESI) source with the following parameters: 
electrospray capillary voltage 3.5 kV; source temperature 
100°C; desolvation temperature 350°C; cone voltage 30. V; 
desolvation gas flow 1000 L/h and cone gas flow 60 L/h. 
Nitrogen was used in the electrospray ionization source. The 
multiplier voltage was set at 650 V. LC-MS was taken in 
positive ionization mode and with the full scan (m/z 50-
1400). The total ion chromatogram, % peak area and mass 
spectrum of the individual peak (appeared in LC) were 
recorded. 
2.4. Isotopic Abundance Ratio Analysis 
The relative intensity of the peak in the mass spectra is 
directly proportional to the relative isotopic abundance of the 
molecule and the isotopic abundance ratio analysis was 
followed by the scientific literature reported [36-39] method 
described as below: 
PM stands for the relative peak intensity of the parent 
molecular ion [M
+
] expressed in percentage. In other way, it 
indicates the probability to A elements having only one 
natural isotope in appreciable abundance (for e. g.
12
C, 
1
H, 
16
O, 
24
Mg, etc.) contributions to the mass of the parent 
molecular ion [M
+
]. 
PM+1 represents the relative peak intensity of the isotopic 
molecular ion [(M+1)
+
] expressed in percentage 
= (no. of 
13
C x 1.1%) + (no. of 
15
N x 0.40%) + (no. of 
2
H x 
0.015%) + (no. of 
17
O x 0.04%) + (no. of 
25
Mg x 12.66%) 
i.e. the probability to A + 1 elements having an isotope that 
has one mass unit heavier than the most abundant isotope (for 
e. g.
13
C, 
2
H, 
17
O, 
25
Mg, etc.) contributions to the mass of the 
isotopic molecular ion [(M+1)
+
]. 
PM+2 represents the relative peak intensity of the isotopic 
molecular ion [(M+2)
+
] expressed in the percentage 
= (no. of 
18
O x 0.20%) + (no. of 
26
Mg x 13.94%) 
i.e. the probability to have A + 2 elements having an 
isotope that has two mass unit heavier than the most 
abundant isotope (for e. g.
18
O, 
26
Mg, etc.) contributions to the 
mass of isotopic molecular ion [(M+2)
+
]. 
Table 1. The isotopic composition (i.e. the natural isotopic abundance) of the 
elements. 
Element Symbol Mass 
% Natural 
Abundance 
A+1 
Factor 
A+2 
Factor 
Hydrogen 1H 1 99.9885   
 2H 2 0.0115 0.015nH  
Carbon 12C 12 98.892   
 13C 13 1.108 1.1 nC  
Oxygen 16O 16 99.762   
 17O 17 0.038 0.04 nO  
 18O 18 0.200  0.20 nO 
Magnesium 24Mg 24 78.99   
 25Mg 25 10.00 12.66 nMg  
 26Mg 26 11.01  13.94 nMg 
A represents element, n represents the number of the 
element (i.e. C, H. O, Mg, etc.) 
The value of the natural isotopic abundance of the 
elements used here for the theoretical calculation are 
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achieved from the scientific literature and are presented in 
the Table 1 [43, 44]. 
Isotopic abundance ratio for A + 1 elements = PM+1/PM 
Similarly, isotopic abundance ratio for A + 2 elements = 
PM+2/PM 
Percentage (%) change in isotopic abundance ratio = 
[(IARTreated – IARControl)/ IARControl) x 100] 
Where, IARTreated = isotopic abundance ratio in the Biofield 
Energy Treated sample and IARControl = isotopic abundance 
ratio in the control sample. 
2.5. Nuclear Magnetic Resonance (NMR) Analysis 
1
H NMR spectra were recorded in a 400 MHZ VARIAN 
FT-NMR spectrometer at room temperature. Data refer to 
solutions in D2O with the residual solvent protons as internal 
references.
1
H NMR multiplicities were designated as singlet 
(s), doublet (d), triplet (t), multiplet (m), and broad (br).
13
C 
NMR spectra were measured at 100 MHz on a VARIAN FT-
NMR spectrometer at room temperature. Chemical shifts (δ) 
were in parts per million (ppm) relative to the solvent’s 
residual proton chemical shift (D2O, δ = 4.65 ppm) and 
solvent’s residual carbon chemical shift (D2O, δ = 0 ppm). 
3. Results and Discussion 
3.1. Liquid Chromatography-Mass Spectrometry (LC-MS) 
Analysis 
The liquid chromatograms of both the control and treated 
magnesium gluconate (Figure 1) showed a sharp and narrow 
peak at the retention time (Rt) of 1.52 min. This finding 
indicated that the polarity/affinity of the Trivedi Effect
®
 - 
Biofield Energy Treated sample remained same compared 
with the control sample. 
The ESI-MS spectra of both the control and treated 
magnesium gluconate at Rt of 1.52 min (Figure 2) exhibited 
the presence of the mass of magnesium gluconate at m/z 415 
[M + H]
+
 (calcd for C12H23MgO14
+
, 415). 
 
Figure 1. Liquid chromatograms of the control and Biofield Energy Treated magnesium gluconate. 
 
Figure 2. The ESI-MS spectra of the control and Biofield Energy Treated magnesium gluconate. 
The typical fragment ion peaks in the lower m/z region of 
the protonated magnesium gluconate ion [M]
+
 (m/z 415) were 
observed in both the control and treated samples at m/z 402 
[M – H2O + 6H]
+
 (calcd for C12H26MgO13
4+
, 402), 381 [M – 
2H2O + 3H]
+
 (calcd for C12H21MgO12
+
, 381), 361 [M – 3H2O 
+ H]
+
 (calcd for C12H17MgO11
+
, 361), and 343 [M – 4H2O + 
H]
+
 (calcd for C12H15MgO10
+
, 343). The fragment ion peaks 
at m/z 320, 307, 279, 225, 206, 183, 165, 142, 135, and 100 
which correspond to the following molecular formula 
C10H16MgO10
+
, C9H15MgO10
+
, C9H3MgO9
2+
, C8H9MgO6
+
, 
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C8H6MgO5
2+
, C6H7MgO5
+
, C5H9O6
+
, C5H2O5
2+
, C5H11O4
+
, 
and C4H4O3
2+
, respectively as shown in the Figure 3 were 
observed in the ESI-MS spectra of both the control and 
treated samples (Figure 2). 
 
Figure 3. Proposed fragmentation pathway of magnesium gluconate. 
Besides, the fragment ion peak at m/z 255, 212, 123 and 
115 corresponding to the molecular formula C9H11MgO7
+
, 
C7H8MgO6
2+
, C4H11O4
+
, and C5H7O3
+
, respectively were only 
found in the control sample. Consequently, the fragment ion 
peaks at m/z 254, 213, 124, and 114 corresponding to the 
molecular formula C9H10MgO7
2+
, C7H9MgO6
+
, C4H12O4
2+
, 
and C5H6O3
2+
 were observed in the ESI-MS spectrum of the 
treated sample. The ESI-MS spectra of the control and 
treated samples (Figure 2) exhibited almost similar type 
fragmentation pattern. The fragment ion peak at m/z 165 
corresponding to C5H9O6
+
 showed 100% relative peak 
intensity in the ESI-MS spectrum of the control sample, 
while the highest intense peak was observed in the ESI-MS 
spectrum of the treated sample at m/z 114 corresponding to 
C5H6O3
2+
 (Figure 2). The relative peak intensities of the other 
ion peaks in the treated sample were significantly altered 
compared with the control sample. 
3.2. Isotopic Abundance Ratio Analysis 
The molecular formula of magnesium gluconate is 
C12H22MgO14. But, it existed as a protonated molecular ion at 
m/z 415 (C12H23MgO14
+
) in the ESI-MS spectrum of the 
control sample that exhibited 34.73% relative intensity. The 
theoretical calculation of PM+1 and PM+2 for the protonated 
magnesium gluconate in the control sample was presented as 
below: 
P (
13
C) = [(12 x 1.1%) x 34.73% (the actual size of the M
+
 
peak)] / 100% = 4.58% 
P (
2
H) = [(23 x 0.015%) x 34.73%] / 100%= 0.12% 
P (
17
O) = [(14 x 0.04%) x 34.73%] / 100% = 0.19% 
P (
25
Mg) = [(1 x 12.66%) x 34.73%] / 100% = 4.40% 
PM+1 i. e.
13
C, 
2
H, 
17
O, and 
25
Mg contributions from 
(C12H23MgO14)
+
 to m/z 416 = 9.29% 
From the above calculation, it has been found that 
13
C and 
25
Mg have major contribution to m/z 416. 
In the similar way, PM+2 can be calculated as follow: 
P (
18
O) = [(14 x 0.20%) x 34.73%] / 100% = 0.97% 
P (
26
Mg) = [(1 x 13.94%) x 34.73%] / 100% = 4.84% 
So, PM+2 i.e.
18
O and 
26
Mg contributions from 
(C12H23MgO14)
+
 to m/z 417 = 5.81%. 
The calculated isotopic abundance ratios of PM+1/PM and 
PM+2/PM were near to the observed value (Table 2). The above 
calculation indicated that 
13
C and 
25
Mg have the major 
contributions from magnesium gluconate to the isotopic peaks. 
LC-MS spectra of the control and treated samples 
indicated the presence of the mass for the protonated 
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magnesium gluconate (m/z 415). Hence, PM, PM+1, PM+2 for 
magnesium gluconate at m/z 415, 416 and 417 of the control 
and Biofield Energy Treated samples were obtained from the 
observed relative peak intensities of [M
+
], [(M+1)
+
], and 
[(M+2)
+
] peaks, respectively in the respective ESI-MS 
spectra are presented in Table 2. 
Table 2. Isotopic abundance analysis results of the magnesium gluconate ion 
in the control and Biofield Energy Treated sample.  
Parameter 
Control 
sample 
Biofield Energy 
Treated sample 
PM at m/z 415 (%) 34.73 23.50 
PM+1 at m/z 416 (%) 10.66 5.95 
PM+1/PM 0.3069 0.2532 
% Change of isotopic abundance ratio 
(PM+1/PM) with respect to the control sample 
 -17.51 
PM+2 at m/z 417 (%) 8.45 10.26 
PM+2/PM 0.2433 0.4366 
% Change of isotopic abundance ratio 
(PM+2/PM) with respect to the control sample 
 79.44 
PM = the relative peak intensity of the parent molecular ion [M
+]; PM+1 = the 
relative peak intensity of the isotopic molecular ion [(M+1)+], PM+2 = the 
relative peak intensity of the isotopic molecular ion [(M+2)+], and M = mass 
of the parent molecule. 
The isotopic abundance ratio of PM+1/PM in the treated 
sample was significantly decreased by 17.51% compared 
with the control sample (Table 2). Consequently, the 
percentage change in the isotopic abundance ratio of PM+2/PM 
was significantly increased by 79.44% in the treated sample 
compared to the control sample. Thus, 
13
C, 
2
H, 
17
O, and 
25
Mg 
contributions from (C12H23MgO14)
+
 to m/z 416; 
18
O and 
26
Mg 
contributions from (C12H23MgO14)
+
 to m/z 417 in the treated 
sample were significantly altered compared with the control 
sample. 
Scientific literature [37-39, 45] reported that the 
vibrational energy is closely related with the reduced mass 
(µ) of the compound and the alteration of the vibrational 
energy can affect the several properties like physicochemical, 
thermal properties of the molecule. The relation between the 
vibrational energy and the reduced mass (µ) for a diatomic 
molecule (Equation 1) is expressed as below [42, 45]: 
 = 	                               (1) 
Where E0 = the vibrational energy of a harmonic oscillator 
at absolute zero or zero point energy, f = force constant 
μ = reduced	mass = 	 + 	 
Where ma and mb are the masses of the constituent atoms. 
The alteration in the isotopic abundance ratios of 
13
C/
12
C 
for C-O; 
2
H/
1
H for C-H and O-H bonds; 
17
O/
16
O and 
18
O/
16
O 
for C-O bond; 
25
Mg/
24
Mg, 
26
Mg/
24
Mg, 
17
O/
16
O and 
18
O/
16
O 
for Mg-O bond have the significant impact on the ground 
state vibrational energy of the molecule due to the higher 
reduced mass (µ) as shown in the Table 3 that leads to the 
isotope effects of the molecule. 
Table 3. Possible isotopic bond and their effect in the vibrational energy in 
magnesium gluconate molecule. 
SL No.  
Probable 
isotopic bond 
Isotope 
type 
Reduced 
mass (µ) 
Zero point vibrational 
energy (E0) 
1 12C-12C Lighter 6.00 Higher 
2 13C-12C Heavier 6.26 Smaller 
3 1H-12C Lighter 0.92 Higher 
4 2H-12C Heavier 1.04 Smaller 
5 12C-16O Lighter 6.86 Higher 
6 13C-16O Heavier 7.17 Smaller 
7 12C-17O Heavier 7.03 Smaller 
8 12C-18O Heavier 7.20 Smaller 
9 16O-1H Lighter 0.94 Higher 
10 16O-2H Heavier 1.78 Smaller 
11 24Mg-16O Lighter 9.60 Higher 
12 25Mg-16O Heavier 9.76 Smaller 
13 26Mg-16O Heavier 9.91 Smaller 
14 24Mg-17O Heavier 9.95 Smaller 
15 24Mg-18O Heavier 10.29 Smaller 
Mass spectroscopic analysis of the several organic 
compounds revealed that the isotopic abundance of [M+1]
+
 
and [M+2]
+
 ions were increased or decreased, thereby 
suggesting the change in number of neutrons in the 
molecule. It was then postulated to the alterations in atomic 
mass and atomic charge through possible mediation of 
neutrino oscillation [37-39, 46]. Thus, it is assumed that 
The Trivedi Effect
®
 - Consciousness Energy Healing 
Treatment might offer the required energy for the neutrino 
oscillations. The changes of neutrinos inside the molecule 
in turn modified the particle size, chemical reactivity, 
density, thermal behavior, selectivity, binding energy, etc. 
[46]. Kinetic isotope effect that is resultant from the 
variation in the isotopic abundance ratio of one of the atoms 
in the reactants in a chemical reaction is very useful to 
study the reaction mechanism as well as for understanding 
the enzymatic transition state and all aspects of enzyme 
mechanism that is supportive for designing enormously 
effective and specific inhibitors [42, 45, 47]. As magnesium 
is an essential cofactor for various enzymatic reactions, 
treated magnesium gluconate that had altered isotopic 
abundance ratio might be advantageous for the study of 
enzyme mechanism as well as support in the designing of 
novel potent enzyme inhibitors. 
3.3. Nuclear Magnetic Resonance (NMR) Analysis 
The 
1
H and 
13
C NMR spectra of the control and treated 
magnesium gluconate are presented in the Figures 4 and 5, 
respectively. Consequently, NMR assignments of the control 
and treated magnesium gluconate are shown in the Table 4. 
Although magnesium gluconate contains a large number of 
hydroxyl (OH) groups, the proton spectra of both the control 
and treated samples did not show any signal for the hydroxyl 
protons due to the replacement of the hydroxyl protons by 
deuterium from deuterated water, which was used as solvent 
for spectra recording. 
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Figure 4. The 1H NMR spectra of the control and Biofield Energy Treated magnesium gluconate. 
 
Figure 5. The 13C NMR spectra of the control and Biofield Energy Treated magnesium gluconate. 
Table 4. 1H NMR and 13C NMR spectroscopic data of both the control and Biofield Energy Treated of magnesium gluconate. 
Position 1H NMR δ (ppm) 13C NMR δ (ppm) 
 Number Control Treated Control Treated 
1, 1ꞌ 4H* 
3.65 (br s), 3.48 3.65 (br s), 3.48 
62.48 62.48 
(dd, J = 12, 8 Hz) (dd, J =12, 4 Hz) 
2, 2ꞌ  2H* 3.59 (br s) 3.59 (br s) 70.69 70.70 
3, 3ꞌ 2H* 3.62 (br s) 3.62 (br s) 71.01 71.02 
4, 4ꞌ 2H 3.88 (br s) 3.88 (br s) 72.22 72.24 
5, 5ꞌ 2H 4.02 (d, J = 4 Hz) 4.02 (d, J = 4 Hz) 73.90 73.91 
6, 6ꞌ --  -- 178.36 178.37 
br- broad, s- singlet, and m- multiplet, * These assignments can be switched. 
The signals for the protons coupling of CH2 group and 
adjacent CH protons (2-5) in the gluconic acid portion were 
observed in the control and treated samples in the range of δ 
3.48 to 4.02 ppm (Table 4), which was almost in accordance 
with the proton spectrum of sodium gluconate [48]. 
Similarly, the carbon signals for CO group, CH2 and CH 
groups in the 
13
C NMR spectrum of the treated sample were 
almost similar compared with the control sample (Table 4). 
So, the structure of the magnesium gluconate in the treated 
sample remained same with the control sample. 
4. Conclusions 
The present study described the structural 
characterization of magnesium gluconate using LC-MS and 
NMR techniques with a significant impact of The Trivedi 
Effect
®
 - Energy of Consciousness Healing Treatment 
(Biofield Energy Healing) on the isotopic abundance ratio 
of PM+1/PM and PM+2/PM. The LC-MS analysis of the both 
control and treated samples indicated the presence of the 
mass of the protonated magnesium gluconate at m/z 415 at 
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the retention time of 1.52 min with similar fragmentation 
pattern. But, the relative peak intensities of the fragment 
ions of the treated sample were significantly altered 
compared with the control sample. The isotopic abundance 
ratio of PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) 
was significantly decreased in the treated sample by 17.51% 
compared with the control sample. Consequently, the 
percentage change in the isotopic abundance ratio of 
PM+2/PM (
18
O/
16
O or 
26
Mg/
24
Mg) was significantly increased 
by 79.44% in the treated sample compared to the control 
sample. Briefly, 
13
C, 
2
H, 
17
O, and 
25
Mg contributions from 
(C12H23MgO14)
+
 to m/z 416; 
18
O and 
26
Mg contributions 
from (C12H23MgO14)
+
 to m/z 417 in the treated sample were 
significantly changed compared with the control sample. 
The treated sample might exhibit isotope effects such as 
altered physicochemical and thermal properties, rate of the 
reaction, selectivity and binding energy due to its reduced 
isotopic abundance ratios of PM+1/PM and PM+2/PM compared 
with the control sample. The treated magnesium gluconate 
might be helpful to understand the enzymatic reactions as 
well as to design the novel potent enzyme inhibitors by 
using its kinetic isotope effects. Besides, The Trivedi 
Effect
® 
- Energy of Consciousness Healing Treatment 
(Biofield Energy Healing Treatment) could be a useful 
approach for the design of better nutraceutical and/or 
pharmaceutical formulations that can offer significant 
therapeutic responses against various diseases such as 
diabetes mellitus, allergies and septic shock; stress-related 
disorders like sleep disorder, insomnia, anxiety, depression, 
Attention Deficit Disorder (ADD), Attention Deficit 
Hyperactive Disorder (ADHD), mental restlessness (mind 
chattering), brain frog, low libido, impotency, lack of 
motivation, mood swings, fear of the future, confusion, 
migraines, headaches, forgetfulness, overwhelm, loneliness, 
worthlessness, indecisiveness, frustration, irritability, 
chronic fatigue, obsessive/compulsive behavior and panic 
attacks; inflammatory diseases and immunological 
disorders like Lupus, Systemic Lupus Erythematosus, 
Hashimoto Thyroiditis, Type 1. Diabetes, Asthma, Chronic 
peptic ulcers, Tuberculosis, Hepatitis, Chronic active 
hepatitis, Celiac Disease (gluten-sensitive enteropathy), 
Addison Disease, Crohn's disease, Graves’ Disease, 
Pernicious and Aplastic Anemia, Sjogren Syndrome, 
Irritable Bowel Syndrome (IBS), Multiple Sclerosis, 
Rheumatoid arthritis, Chronic periodontitis, Ulcerative 
colitis, Chronic sinusitis, Myasthenia Gravis, 
Atherosclerosis, Vasculitis, Dermatitis, Diverticulitis, 
Rheumatoid Arthritis, Reactive Arthritis, Alopecia Areata, 
Psoriasis, Scleroderma, Fibromyalgia, Chronic Fatigue 
Syndrome and Vitiligo; aging-related diseases like 
cardiovascular disease, arthritis, cancer, Alzheimer’s 
disease, dementia, cataracts, osteoporosis, diabetes, 
hypertension, glaucoma, hearing loss, Parkinson’s Disease, 
Huntington’s Disease, Prion Disease, Motor Neurone 
Disease, Spinocerebellar Ataxia, Spinal muscular atrophy, 
Amyotrophic lateral sclerosis, Friedreich’s Ataxia and 
Lewy Body Disease, chronic infections and many more. 
Abbreviations 
A: Element; LC-MS: Liquid chromatography-mass 
spectrometry; M: Mass of the parent molecule; m/z: Mass-to-
charge ratio; n: Number of the element; NMR: Nuclear 
magnetic resonance spectroscopy; PM: The relative peak 
intensity of the parent molecular ion [M
+
]; PM+1: The relative 
peak intensity of isotopic molecular ion [(M+1)
+
]); PM+2: The 
relative peak intensity of isotopic molecular ion [(M+2)
+
]); 
Rt: Retention time. 
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